Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells

MedicalXpress | juil. 24, 2026

Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them. KAIST researchers have now succeeded in precisely targeting intracellular cancer mutations using a newly designed antibody created through computational methods.